{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:58:45Z","timestamp":1790366325698,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic inflammation is one of the causes of neurodegeneration in Amyotrophic lateral sclerosis (ALS). Here we examined whether circulating dendritic cells (DCs) can contribute to disease progression. We found ALS patients show a significant reduction in the number of circulating DCs. Also, patients\u2019 DCs present an increased expression of CD62L and a tendency to overexpress CCR2 compared with healthy donors. Moreover, DCs derived from a subpopulation of ALS patients produced higher levels of IL-8 and CCL-2 upon lipopolysaccharide (LPS)-stimulation. Finally, we found a significant inverse correlation between the time from onset of the pathology to its diagnosis and the levels of IL-6 secretion induced by LPS. Our data support the hypothesis, in a subpopulation of patients, DCs recruited at the diseased tissue produce high levels of CCL-2 and IL-8 and contribute to the inflammatory process promoting the recruitment of other inflammatory cells. An increased efficiency of IL-6 production may accelerate only the initial phases of disease progression. Blood DC analysis can be used to identify ALS patients with an altered course of inflammatory cell recruitment at the diseased central nervous system (CNS). The high levels of CD62L expression suggests this molecule could be a target for treatment of CNS inflammation.<\/jats:p>","DOI":"10.1038\/s41598-017-08233-1","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T15:23:12Z","timestamp":1501860192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Inflammatory role of dendritic cells in Amyotrophic Lateral Sclerosis revealed by an analysis of patients\u2019 peripheral blood"],"prefix":"10.1038","volume":"7","author":[{"given":"Michela","family":"Rusconi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gerardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Santus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Ada","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lunetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Zanoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Granucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,10]]},"reference":[{"key":"8233_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/archneur.58.3.512","volume":"58","author":"LP Rowland","year":"2001","unstructured":"Rowland, L. P. How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot. Archives of neurology \n                           58, 512\u2013515 (2001).","journal-title":"Archives of neurology"},{"issue":"Pt B","key":"8233_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.expneurol.2013.11.006","volume":"262","author":"J Hardy","year":"2014","unstructured":"Hardy, J. & Rogaeva, E. Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not. Experimental neurology \n                           262(Pt B), 75\u201383, doi:10.1016\/j.expneurol.2013.11.006 (2014).","journal-title":"Experimental neurology"},{"key":"8233_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen, D. R. et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature \n                           362, 59\u201362, doi:10.1038\/362059a0 (1993).","journal-title":"Nature"},{"key":"8233_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1046\/j.0009-9163.2002.00001.x","volume":"63","author":"D Majoor-Krakauer","year":"2003","unstructured":"Majoor-Krakauer, D., Willems, P. J. & Hofman, A. Genetic epidemiology of amyotrophic lateral sclerosis. Clinical genetics \n                           63, 83\u2013101 (2003).","journal-title":"Clinical genetics"},{"key":"8233_CR5","first-page":"386","volume":"54","author":"S Cluskey","year":"2001","unstructured":"Cluskey, S. & Ramsden, D. B. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Molecular pathology: MP \n                           54, 386\u2013392 (2001).","journal-title":"Molecular pathology: MP"},{"key":"8233_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/intimm\/dxu099","volume":"27","author":"A Malaspina","year":"2015","unstructured":"Malaspina, A., Puentes, F. & Amor, S. Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective. International immunology \n                           27, 117\u2013129, doi:10.1093\/intimm\/dxu099 (2015).","journal-title":"International immunology"},{"key":"8233_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0014-5793(02)03546-9","volume":"531","author":"S Ishigaki","year":"2002","unstructured":"Ishigaki, S. et al. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords\u2013screening by molecular indexing and subsequent cDNA microarray analysis. FEBS letters \n                           531, 354\u2013358 (2002).","journal-title":"FEBS letters"},{"key":"8233_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1152\/physiolgenomics.00087.2001","volume":"16","author":"F Dangond","year":"2004","unstructured":"Dangond, F. et al. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiological genomics \n                           16, 229\u2013239, doi:10.1152\/physiolgenomics.00087.2001 (2004).","journal-title":"Physiological genomics"},{"key":"8233_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ana.10805","volume":"55","author":"JS Henkel","year":"2004","unstructured":"Henkel, J. S. et al. Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol \n                           55, 221\u2013235, doi:10.1002\/ana.10805 (2004).","journal-title":"Ann Neurol"},{"key":"8233_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/14660820410020286","volume":"5","author":"MC Graves","year":"2004","unstructured":"Graves, M. C. et al. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases \n                           5, 213\u2013219 (2004).","journal-title":"Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases"},{"key":"8233_CR11","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1523\/JNEUROSCI.4786-03.2004","volume":"24","author":"MD Nguyen","year":"2004","unstructured":"Nguyen, M. D., D\u2019Aigle, T., Gowing, G., Julien, J. P. & Rivest, S. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. The Journal of neuroscience: the official journal of the Society for Neuroscience \n                           24, 1340\u20131349, doi:10.1523\/JNEUROSCI.4786-03.2004 (2004).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"8233_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/emmm.201201544","volume":"5","author":"JS Henkel","year":"2013","unstructured":"Henkel, J. S. et al. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO molecular medicine \n                           5, 64\u201379, doi:10.1002\/emmm.201201544 (2013).","journal-title":"EMBO molecular medicine"},{"key":"8233_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jneuroim.2008.09.017","volume":"206","author":"R Zhang","year":"2009","unstructured":"Zhang, R. et al. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). Journal of neuroimmunology \n                           206, 121\u2013124, doi:10.1016\/j.jneuroim.2008.09.017 (2009).","journal-title":"Journal of neuroimmunology"},{"key":"8233_CR14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B","volume":"43","author":"LR Wedderburn","year":"2000","unstructured":"Wedderburn, L. R., Robinson, N., Patel, A., Varsani, H. & Woo, P. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis and rheumatism \n                           43, 765\u2013774, doi:10.1002\/1529-0131(200004)43:4765::AID-ANR73.0.CO;2-B (2000).","journal-title":"Arthritis and rheumatism"},{"key":"8233_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fimmu.2014.00042","volume":"5","author":"F Granucci","year":"2014","unstructured":"Granucci, F., Lutz, M. B. & Zanoni, I. The nature of activatory and tolerogenic dendritic cell-derived signal 2. Frontiers in immunology \n                           5, 42, doi:10.3389\/fimmu.2014.00042 (2014).","journal-title":"Frontiers in immunology"},{"key":"8233_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1084\/jem.194.6.863","volume":"194","author":"N Kadowaki","year":"2001","unstructured":"Kadowaki, N. et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. The Journal of experimental medicine \n                           194, 863\u2013869 (2001).","journal-title":"The Journal of experimental medicine"},{"key":"8233_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","volume":"140","author":"C Nathan","year":"2010","unstructured":"Nathan, C. & Ding, A. Nonresolving inflammation. Cell \n                           140, 871\u2013882, doi:10.1016\/j.cell.2010.02.029 (2010).","journal-title":"Cell"},{"key":"8233_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12974-014-0201-8","volume":"11","author":"H Gonzalez","year":"2014","unstructured":"Gonzalez, H. & Pacheco, R. T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. Journal of neuroinflammation \n                           11, 201, doi:10.1186\/s12974-014-0201-8 (2014).","journal-title":"Journal of neuroinflammation"},{"key":"8233_CR19","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s11481-013-9489-x","volume":"8","author":"W Zhao","year":"2013","unstructured":"Zhao, W., Beers, D. R. & Appel, S. H. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology \n                           8, 888\u2013899, doi:10.1007\/s11481-013-9489-x (2013).","journal-title":"Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology"},{"key":"8233_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks, B. R., Miller, R. G., Swash, M. & Munsat, T. L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases \n                           1, 293\u2013299 (2000).","journal-title":"Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases"},{"key":"8233_CR21","doi-asserted-by":"publisher","unstructured":"Villani, A. C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science \n                           356, 283\u2212+, doi:10.1126\/science.aah4573 (2017).","DOI":"10.1126\/science.aah4573"},{"key":"8233_CR22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nri3070","volume":"11","author":"C Shi","year":"2011","unstructured":"Shi, C. & Pamer, E. G. Monocyte recruitment during infection and inflammation. Nature reviews. Immunology \n                           11, 762\u2013774, doi:10.1038\/nri3070 (2011).","journal-title":"Nature reviews. Immunology"},{"key":"8233_CR23","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/jcbfm.2014.120","volume":"34","author":"HX Chu","year":"2014","unstructured":"Chu, H. X. et al. Role of CCR2 in inflammatory conditions of the central nervous system. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism \n                           34, 1425\u20131429, doi:10.1038\/jcbfm.2014.120 (2014).","journal-title":"Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"8233_CR24","doi-asserted-by":"publisher","unstructured":"Villani, A. C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science \n                           356, doi:10.1126\/science.aah4573 (2017).","DOI":"10.1126\/science.aah4573"},{"key":"8233_CR25","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1172\/JCI62636","volume":"122","author":"O Butovsky","year":"2012","unstructured":"Butovsky, O. et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. The Journal of clinical investigation \n                           122, 3063\u20133087, doi:10.1172\/JCI62636 (2012).","journal-title":"The Journal of clinical investigation"},{"key":"8233_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/mus.20376","volume":"32","author":"P Baron","year":"2005","unstructured":"Baron, P. et al. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle & nerve \n                           32, 541\u2013544, doi:10.1002\/mus.20376 (2005).","journal-title":"Muscle & nerve"},{"key":"8233_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1742-2094-8-47","volume":"8","author":"PK Gupta","year":"2011","unstructured":"Gupta, P. K., Prabhakar, S., Sharma, S. & Anand, A. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. Journal of neuroinflammation \n                           8, 47, doi:10.1186\/1742-2094-8-47 (2011).","journal-title":"Journal of neuroinflammation"},{"key":"8233_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jneuroim.2004.10.009","volume":"159","author":"R Zhang","year":"2005","unstructured":"Zhang, R. et al. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). Journal of neuroimmunology \n                           159, 215\u2013224, doi:10.1016\/j.jneuroim.2004.10.009 (2005).","journal-title":"Journal of neuroimmunology"},{"key":"8233_CR29","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood.V90.9.3245","volume":"90","author":"DN Hart","year":"1997","unstructured":"Hart, D. N. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood \n                           90, 3245\u20133287 (1997).","journal-title":"Blood"},{"key":"8233_CR30","first-page":"187","volume":"50","author":"P Iribarren","year":"2002","unstructured":"Iribarren, P., Cui, Y. H., Le, Y. & Wang, J. M. The role of dendritic cells in neurodegenerative diseases. Archivum immunologiae et therapiae experimentalis \n                           50, 187\u2013196 (2002).","journal-title":"Archivum immunologiae et therapiae experimentalis"},{"key":"8233_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2006.06.008","volume":"179","author":"R Zhang","year":"2006","unstructured":"Zhang, R. et al. MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS). Journal of neuroimmunology \n                           179, 87\u201393, doi:10.1016\/j.jneuroim.2006.06.008 (2006).","journal-title":"Journal of neuroimmunology"},{"key":"8233_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jneuroim.2009.02.012","volume":"210","author":"S Mantovani","year":"2009","unstructured":"Mantovani, S. et al. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. Journal of neuroimmunology \n                           210, 73\u201379, doi:10.1016\/j.jneuroim.2009.02.012 (2009).","journal-title":"Journal of neuroimmunology"},{"key":"8233_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1468-1331.2004.00796.x","volume":"11","author":"TL Sorensen","year":"2004","unstructured":"Sorensen, T. L., Ransohoff, R. M., Strieter, R. M. & Sellebjerg, F. Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis. European journal of neurology \n                           11, 445\u2013449, doi:10.1111\/j.1468-1331.2004.00796.x (2004).","journal-title":"European journal of neurology"},{"key":"8233_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.mcn.2005.10.016","volume":"31","author":"JS Henkel","year":"2006","unstructured":"Henkel, J. S., Beers, D. R., Siklos, L. & Appel, S. H. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Molecular and cellular neurosciences \n                           31, 427\u2013437, doi:10.1016\/j.mcn.2005.10.016 (2006).","journal-title":"Molecular and cellular neurosciences"},{"key":"8233_CR35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/jlb.65.5.665","volume":"65","author":"JJ Bright","year":"1999","unstructured":"Bright, J. J., Xin, Z. & Sriram, S. Superantigens augment antigen-specific Th1 responses by inducing IL-12 production in macrophages. Journal of leukocyte biology \n                           65, 665\u2013670 (1999).","journal-title":"Journal of leukocyte biology"},{"key":"8233_CR36","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1468-1331.2009.02560.x","volume":"16","author":"J Kuhle","year":"2009","unstructured":"Kuhle, J. et al. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. European journal of neurology \n                           16, 771\u2013774, doi:10.1111\/j.1468-1331.2009.02560.x (2009).","journal-title":"European journal of neurology"},{"key":"8233_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1212\/01.wnl.0000333251.36681.a5","volume":"72","author":"RM Mitchell","year":"2009","unstructured":"Mitchell, R. M. et al. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology \n                           72, 14\u201319, doi:10.1212\/01.wnl.0000333251.36681.a5 (2009).","journal-title":"Neurology"},{"key":"8233_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/tcrm.2007.3.2.259","volume":"3","author":"M Hutchinson","year":"2007","unstructured":"Hutchinson, M. Natalizumab: A new treatment for relapsing remitting multiple sclerosis. Therapeutics and clinical risk management \n                           3, 259\u2013268 (2007).","journal-title":"Therapeutics and clinical risk management"},{"key":"8233_CR39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000360528","volume":"72","author":"CP Kamm","year":"2014","unstructured":"Kamm, C. P., Uitdehaag, B. M. & Polman, C. H. Multiple sclerosis: current knowledge and future outlook. European neurology \n                           72, 132\u2013141, doi:10.1159\/000360528 (2014).","journal-title":"European neurology"},{"key":"8233_CR40","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/imj.12558","volume":"44","author":"L Sedal","year":"2014","unstructured":"Sedal, L., Wilson, I. B. & McDonald, E. A. Current management of relapsing-remitting multiple sclerosis. Internal medicine journal \n                           44, 950\u2013957, doi:10.1111\/imj.12558 (2014).","journal-title":"Internal medicine journal"},{"key":"8233_CR41","doi-asserted-by":"publisher","first-page":"42959","DOI":"10.1074\/jbc.M111.295758","volume":"286","author":"C Garbers","year":"2011","unstructured":"Garbers, C. et al. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor. The Journal of biological chemistry \n                           286, 42959\u201342970, doi:10.1074\/jbc.M111.295758 (2011).","journal-title":"The Journal of biological chemistry"},{"key":"8233_CR42","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1517\/14712598.2012.707178","volume":"12","author":"Z Ash","year":"2012","unstructured":"Ash, Z. & Emery, P. The role of tocilizumab in the management of rheumatoid arthritis. Expert opinion on biological therapy \n                           12, 1277\u20131289, doi:10.1517\/14712598.2012.707178 (2012).","journal-title":"Expert opinion on biological therapy"},{"key":"8233_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/BOR.0b013e3283456797","volume":"23","author":"M Murakami","year":"2011","unstructured":"Murakami, M. & Nishimoto, N. The value of blocking IL-6 outside of rheumatoid arthritis: current perspective. Current opinion in rheumatology \n                           23, 273\u2013277, doi:10.1097\/BOR.0b013e3283456797 (2011).","journal-title":"Current opinion in rheumatology"},{"key":"8233_CR44","first-page":"305","volume":"1","author":"MT Mizwicki","year":"2012","unstructured":"Mizwicki, M. T. et al. Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling. American journal of neurodegenerative disease \n                           1, 305\u2013315 (2012).","journal-title":"American journal of neurodegenerative disease"},{"key":"8233_CR45","first-page":"129","volume":"2","author":"M Fiala","year":"2013","unstructured":"Fiala, M., Mizwicki, M. T., Weitzman, R., Magpantay, L. & Nishimoto, N. Tocilizumab infusion therapy normalizes inflammation in sporadic ALS patients. American journal of neurodegenerative disease \n                           2, 129\u2013139 (2013).","journal-title":"American journal of neurodegenerative disease"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08233-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08233-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08233-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:31:36Z","timestamp":1671784296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08233-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,10]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["8233"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-08233-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,10]]},"assertion":[{"value":"17 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7853"}}